[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100280685":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":24,"centralContacts":24,"locations":24,"responsibleParty":32,"collaborators":24,"id":34,"slug":35,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":24,"acronym":24,"eligibilityCriteria":39,"healthyVolunteers":40,"sex":41,"minAge":42,"maxAge":43,"enrollmentInfo":44,"targetDuration":24,"studyType":47,"phases":48,"briefSummary":50,"conditions":51,"keywords":24,"overallStatus":53,"whyStopped":24,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":58,"completionDateStruct":24,"leadSponsor":60,"locationsCount":24},{"fullName":5,"class":6},"Daewon Pharmaceutical Co., Ltd.","INDUSTRY",[8,16],{"label":9,"type":10,"description":11,"interventionNames":12},"Reference1","EXPERIMENTAL","single(Reference1) -\\> combination(Reference1+Reference2)",[13,14,15],"Drug: Telmisartan","Drug: Amlodipine","Drug: Rosuvastatin",{"label":17,"type":10,"description":18,"interventionNames":19},"Reference2","single(Reference2) -\\> combination(Reference1+Reference2)",[13,14,15],[21,26,29],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":24},"DRUG","Telmisartan",null,[9,17],{"type":22,"name":27,"description":24,"armGroupLabels":28,"otherNames":24},"Amlodipine",[9,17],{"type":22,"name":30,"description":24,"armGroupLabels":31,"otherNames":24},"Rosuvastatin",[9,17],{"type":33,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR","100280685","phase-1-study-of-multiple-oral-dosing-to-evaluate-the-safety-and-the-pharmacokinetic-drug-drug-interaction-of-telmisartanamlodipine-and-rosuvastatin-in-healthy-male-volunteers-100280685",false,"NCT02933658","Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan\u002FAmlodipine and Rosuvastatin in Healthy Male Volunteers","Inclusion Criteria:\n\n* Healthy male who are ≥19, \\\u003C50 years old\n* Man who weights over 55kg and whose BMI is 18\\~30(kg\u002Fm2)\n* Man who doesn't have any chronic disease or history of disease\n\nExclusion Criteria:\n\n* man who has or had any clinically relevant disease of liver, kidney, nervous\u002Frespiratory\u002Fmusculoskeletal\u002Fcardiovascular\u002Fhemato-oncology system or neuropsychiatry",true,"MALE","19 Years","49 Years",{"count":45,"type":46},71,"ACTUAL","INTERVENTIONAL",[49],"PHASE1","A non-randomized, two-arm, single-sequence, crossover, open label, multiple oral dosing clinical trial to evaluate the safety and the pharmacokinetic drug-drug interaction of Telmisartan\u002FAmlodipine and Rosuvastatin in healthy male volunteers",[52],"Hypertension and Dyslipidemia","COMPLETED","2016-10-12",{"date":56,"type":57},"2016-10-14","ESTIMATED",{"date":59,"type":24},"2015-11",{"name":5,"class":6}]